Injectable Cement Market By Type (Low Viscosity Cement, Medium Viscosity Cement, High Viscosity Cement), By Application (Spine Fusion, Bone fracture, Others), By End User (Hospital, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global injectable cement market was valued at $1,321.7 million in 2021, and is projected to reach $2,297.0 million by 2031, registering a CAGR of 5.7% from 2022 to 2031. Injectable cement is the synthetic materials used for filling spaces between the prosthesis and bone and provides elasticity. It is used as an adhesive in hip replacement surgery to keep implant in place. It is also used to provide strength for bone stability. Injectable cement is biocompatible and osteoconductive synthetic materials. There are different types of bone cement that are classified on the basis of viscosity, such as low viscosity cement, medium viscosity cement, and highly viscous cement. The viscosity of bone cement affects its properties, including handling time, fixing quality, bone penetration, and stability. Currently available injectable cement includes, calcium sulfate cement and polymethylmethacrylate (PMMA).
The injectable cement market growth is driven by rise in geriatric population, increase in accidental cases, and surge in surgeries performed for hip replacement. For instance, according to the National Highway Traffic Safety Administration (NHTSA), a noticeable increase of 10.5% fatalities was reported in 2021 in the U.S. Furthermore, according to Organisation for Economic Co-operation and Development (OCED) library, in 2019, Germany, Austria, Finland, and Switzerland were among the countries with highest rates for hip and knee replacement. In addition, as per the same source, hip replacement rates increased by 22% between 2009 and 2019 in OECD countries. Moreover, rise in demand for injectable cement drives the growth of the market. In addition, increase in use of injectable cement in the dentistry sector is anticipated to contribute toward the growth of the market. Furthermore, rise in prevalence of bone diseases leads to increase in the number of orthopedic surgeries, which further fosters the market growth.
Moreover, increase in prevalence of bone diseases, such as bone infection, bone tumor, and osteoporosis, leads to increase in the number of orthopedic surgeries, which further fosters the market growth.
However, the high cost associated with surgery and shortage of skilled surgeons hinder the growth of the market. For instance, the cost of total knee replacement surgery without insurance is about $19,995 in the U.S. Moreover, clinical barriers of injectable cement and low penetration act as a major restraint of the global injectable cement market. On the other side, increase in healthcare expenditure and increase in the number of specialized hospitals in countries, such as China and India are expected to create opportunities for the growth of the market.
The injectable cement market is segmented into type, application, end user, and region. By type, the market is segregated into low viscosity cement, medium viscosity cement, and high viscosity cement. On the basis of application, the market is categorized into spine fusion, bone fracture, and others. The others segment includes, craniomaxillofacial and dental bone grafting. Depending on end user, the market is fragmented into hospital, clinics, and others. The others segment includes, research centers and spine centers. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).
Major key players that operate in the global injectable cement market are Arthrex Inc., B. Braun Melsungen AG, Cook Medical, Enovis, Johnson and Johnson , Medacta International SA, Medtronic plc, Smith and Nephew, Stryker Corporation, and Teknimed.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the injectable cement market analysis from 2021 to 2031 to identify the prevailing injectable cement market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the injectable cement market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global injectable cement market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
High Viscosity Cement
Low Viscosity Cement
Medium Viscosity Cement
By Application
Spine Fusion
Bone fracture
Others
By End User
Hospital
Clinics
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Arthrex
cook medical
Enovis (DJO Global, Inc.)
johnson and johnson md&d
Medacta International SA
smith and nephew
Stryker Corporation
B. Braun Melsungen AG
Medtronic plc
Teknimed
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook